Vinorelbine as second-line treatment of NSCLC after the failure of platinumtaxane combination at the Hue University Hospital
Original article | No. 51 (2018)
Journal of Clinical Medicine Hue Central Hospital, No. 51 (2018)
Original article

Vinorelbine as second-line treatment of NSCLC after the failure of platinumtaxane combination at the Hue University Hospital

DOI: 10.38103.51.5
10.38103.51.5
  • Ho Xuan Dung
  • Le Vi
  • Nguyen Tuan Phat
  • Tran Doan Quoc Long
  • Le Gia Han
  • Nguyen Thi Thuy
Ho Xuan Dung
Le Vi
Nguyen Tuan Phat
Tran Doan Quoc Long
Le Gia Han
Nguyen Thi Thuy

Downloads

Download data is not yet available.
PDF     98    54

Abstract

.

https://doi.org/10.38103.51.5

References

.

Published 16-01-2025
Fulltext
PDF     98    54
Language
Tiếng Việt
Issue No. 51 (2018)
Section Original article
DOI 10.38103.51.5
Keywords NSCLC, lung cancer, vinorelbine, second-line
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital

Dung, H. X., Vi, L., Phat, N. T., Long, T. D. Q., Han, L. G., & Thuy, N. T. (2025). Vinorelbine as second-line treatment of NSCLC after the failure of platinumtaxane combination at the Hue University Hospital. Journal of Clinical Medicine Hue Central Hospital, 10(51), 68–72. https://doi.org/10.38103.51.5
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
© 2024 Hue Central Hospital - Designed by OJSVN